The FREESIA-3 research study is investigating a new treatment for FNAIT, a rare condition that affects a baby’s platelet count during pregnancy. Pregnant women at risk may qualify for free study medication, care, and health evaluations for mother and baby. Learn more about this opportunity today!
Briana Gray’s journey to motherhood is marked with love, loss, and healing. After losing her son Elijah to FNAIT, she found strength through supportive care and determination. Now raising her sons Callum and Noah, Briana honors Elijah’s memory while embracing the joys of motherhood.
3-minute read
Parents aren’t the only ones who may not be aware of the dire consequences of FNAIT. Many doctors and other medical professionals aren’t familiar with the blood disorder until there’s a serious problem. Raising awareness allows for better disease management and prevention. See how the McGrew family dealt with four FNAIT pregnancies.
2-minute read
When a baby experiences FNAIT or NAIT it’s often not discovered until symptoms appear. That’s why it’s important to know the signs and understand if you and your pregnancy are at risk. The consequences of this condition that involves a low blood platelet count can be alleviated through awareness and prompt action.
I was diagnosed with fetomaternal alloimmunization, a condition in which a mother’s body creates antibodies against a fetus’ blood antigens. This diagnosis crushed us. My husband and I wanted a lot of children, and now we were left wondering whether we could even have a second.
After a diagnosis of maternal fetal alloimmunization and losing baby Lucy to hemolytic disease of the fetus and newborn (HDFN), Bethany took action. She made it her mission to ensure that other mothers diagnosed with maternal alloimmunization had education about the risks of the disease and knew the steps for proper medical care and treatment so that their babies could survive HDFN.